ConductScience.org, home

Paper21394465

Cyclophosphamide in steroid-dependent nephrotic syndrome.

Azib S and 7 others. Pediatr Nephrol, 2011. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Cyclophosphamide in steroid-dependent nephrotic syndrome. Papers, record 21394465. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21394465

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cyclophosphamide in steroid-dependent nephrotic syndrome.
PubMed
Journal
Pediatr Nephrol
PubMed
Year
2011
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
1.15
iCite
Revised in PubMed
2021-10-20
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Azib SSonia
2Macher MAMarie Alice
3Kwon TTheresa
4Dechartres AAgnes
5Alberti CCorinne
6Loirat CChantal
7Deschênes GGeorges
8Baudouin VVéronique

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CyclophosphamideMajor topic
GlucocorticoidsMajor topic
Immunosuppressive AgentsMajor topic
Nephrotic SyndromeMajor topic
PrednisoneMajor topic
Age Factors
Child
Child, Preschool
Disease-Free Survival
Drug Therapy, Combination
Female
Humans
Male
Remission Induction
Retrospective Studies
Treatment Outcome

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in21710249Cyclophosphamide followed by mizoribine as maintenance therapy against refractory steroid-dependent nephrotic syndrome.https://conductscience.org/library/papers/21710249

Source PubMed

Download CSV of comments and corrections

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14194935Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood.Lancet1970https://conductscience.org/library/papers/4194935PubMed
2713276Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children.Kidney Int1978https://conductscience.org/library/papers/713276PubMed
37035953Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence.N Engl J Med1982https://conductscience.org/library/papers/7035953PubMed
415968558Evidence-based management of steroid-sensitive nephrotic syndrome.Pediatr Nephrol2005https://conductscience.org/library/papers/15968558PubMed
54137139Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.Lancet1974https://conductscience.org/library/papers/4137139PubMed
611322378A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children.Pediatr Nephrol2001https://conductscience.org/library/papers/11322378PubMed
79745870Influence of age at onset on the outcome of steroid-sensitive nephrotic syndrome.Pediatr Nephrol1998https://conductscience.org/library/papers/9745870PubMed
810955925Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome.Pediatr Nephrol2000https://conductscience.org/library/papers/10955925PubMed
98159300Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.Nephrol Dial Transplant1993https://conductscience.org/library/papers/8159300PubMed
1012612977Steroid-sensitive nephrotic syndrome: from childhood to adulthood.Am J Kidney Dis2003https://conductscience.org/library/papers/12612977PubMed
1118254005Non-corticosteroid treatment for nephrotic syndrome in children.Cochrane Database Syst Rev2008https://conductscience.org/library/papers/18254005PubMed
123933709Long term effects of cyclophosphamide on testicular function.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/3933709PubMed
132248508Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.Arch Dis Child1990https://conductscience.org/library/papers/2248508PubMed
1417472840Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.Am J Kidney Dis2007https://conductscience.org/library/papers/17472840PubMed
159874319Long-term effects of immunosuppressants in steroid-dependent nephrotic syndrome.Pediatr Nephrol1998https://conductscience.org/library/papers/9874319PubMed
16621614Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy.J Pediatr1978https://conductscience.org/library/papers/621614PubMed
171482637How to manage a child with steroid-responsive nephrotic syndrome when dose of prednisolone is reduced or when placed on high-dose alternate day steroids.Pediatr Nephrol1992https://conductscience.org/library/papers/1482637PubMed
187459891PLasma half-life and urinary excretion of cyclophosphamide in children.Cancer Treat Rep1980https://conductscience.org/library/papers/7459891PubMed
193688915Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.Arch Dis Child1987https://conductscience.org/library/papers/3688915PubMed
208824688Cyclophosphamide pharmacokinetics in children.Br J Clin Pharmacol1996https://conductscience.org/library/papers/8824688PubMed

See all 27 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
42867774Follow-up Outcomes of 100 Children with Frequently Relapsing and Steroid Dependent Nephrotic Syndrome Treated with Oral Cyclophosphamide: A Retrospective Cohort Study.Indian Pediatr2026https://conductscience.org/library/papers/42867774PubMed
41522688The 2025 KDIGO guideline on the management of nephrotic syndrome in children: a comment of the European Renal Association Immunonephrology Working Group.Clin Kidney J2026https://conductscience.org/library/papers/41522688PubMed
41448676
Obinutuzumab versus Rituximab to maintain remission in children with steroid-dependent and frequently relapsing nephrotic syndrome: the OBIRINS study protocol, a double-blind randomised controlled trial.
BMJ Open2025https://conductscience.org/library/papers/41448676PubMed
39576325Prolonged remission after cyclophosphamide or tacrolimus treatment in childhood nephrotic syndrome: a cohort study.Pediatr Nephrol2025https://conductscience.org/library/papers/39576325PubMed
37477752Predictive factors of long-term disease remission after rituximab administration in patients with childhood-onset complicated steroid-dependent nephrotic syndrome: a single-center retrospective study.Clin Exp Nephrol2023https://conductscience.org/library/papers/37477752PubMed
34767076
Long-term obesity prevalence and linear growth in children with idiopathic nephrotic syndrome: is normal growth and weight control possible with steroid-sparing drugs and low-dose steroids for relapses?
Pediatr Nephrol2022https://conductscience.org/library/papers/34767076PubMed
33786660Oral cyclophosphamide therapy in 100 children with steroid-sensitive nephrotic syndrome: experience from a developing country.Pediatr Nephrol2021https://conductscience.org/library/papers/33786660PubMed
32967877
Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial.
BMJ Open2020https://conductscience.org/library/papers/32967877PubMed
30121800Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome.Clin Exp Nephrol2019https://conductscience.org/library/papers/30121800PubMed
29869116Treating the idiopathic nephrotic syndrome: are steroids the answer?Pediatr Nephrol2019https://conductscience.org/library/papers/29869116PubMed
27778092Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic?Pediatr Nephrol2016https://conductscience.org/library/papers/27778092PubMed
27558467Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.Clin Exp Nephrol2017https://conductscience.org/library/papers/27558467PubMed
27263020Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.Pediatr Nephrol2016https://conductscience.org/library/papers/27263020PubMed
26078695Long-term results of children diagnosed with idiopathic nephrotic syndrome; single center experience.Turk Pediatri Ars2015https://conductscience.org/library/papers/26078695PubMed
25653046Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy.Clin Exp Nephrol2015https://conductscience.org/library/papers/25653046PubMed
25028636Chapter 3: Steroid-sensitive nephrotic syndrome in children.Kidney Int Suppl (2011)2012https://conductscience.org/library/papers/25028636PubMed
24899237Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome.Pediatr Nephrol2014https://conductscience.org/library/papers/24899237PubMed
22729760Is cyclophosphamide effective in patients with IgM-positive minimal change disease?Pediatr Nephrol2012https://conductscience.org/library/papers/22729760PubMed
21947272Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial.Pediatr Nephrol2012https://conductscience.org/library/papers/21947272PubMed
21710249Cyclophosphamide followed by mizoribine as maintenance therapy against refractory steroid-dependent nephrotic syndrome.Pediatr Nephrol2011https://conductscience.org/library/papers/21710249PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21394465

GET https://conductscience.org/api/papers/v1/21394465/references?page=2